GEN Exclusives

More »

GEN News Highlights

Back to Item »

Ariad Reports Positive Preliminary Results from Pivotal Ponatinib CML Trial

Early data demonstrate therapy leads to improved cytogenetic and molecular response rates in heavily pretreated and Ph+ patients.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?